Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles

by Varn, Frederick S., Andrews, Erik H., Mullins, David W., Cheng, Chao
Published 2016

CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity

by Jenkins, Molly H., Brinckerhoff, Constance E., Mullins, David W.
Published 2015

The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells

by Jenkins, Molly H., Croteau, Walburga, Mullins, David W., Brinckerhoff, Constance E.
Published 2015

Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor...

by Mullins, David W., Sheasley, Stacey L., Ream, Rebecca M., Bullock, Timothy N.J., Fu, Yang-Xin, Engelhard, Victor H.
Published 2003

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

by Bressler, Brian, Bethel, Kevin P., Kleef, Ralf, Reynolds, Sophie L., Sutcliffe, Simon, Mullins, David W., Gunn, Hal
Published 2015

Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy

by Colella, Teresa A., Bullock, Timothy N.J., Russell, Liane B., Mullins, David W., Overwijk, Willem W., Luckey, Chance John, Pierce, Richard A., Restifo, Nicholas P., Engelhard, Victor H.
Published 2000

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

by Mauldin, Ileana S, Wages, Nolan A, Stowman, Anne M, Wang, Ena, Smolkin, Mark E, Olson, Walter C, Deacon, Donna H, Smith, Kelly T, Galeassi, Nadejda, Teague, Jessica E, Clark, Rachael A, Marincola, Francesco M, Petroni, Gina R, Mullins, David W, Slingluff, Craig L
Published 2015